Elevated interleukin-33, CD1c+ dendritic cells, and interleukin-17A in peritoneal fluid of patients with endometriosis: a case-control study

Wen Yuan, Yuan W, Huang J, Jiao Huang, Tao He, He T, Li H, Huanni Li, Wu X, Xianqing Wu
Molecular biology reports · 2026 · vol. 53(1) · doi:10.1007/s11033-026-12457-8 · PMID:42593546 · W7202393432
Observational OA: closed public-domain-us
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-08-20 ⓘ

This case-control study found that peritoneal fluid from endometriosis patients exhibits elevated interleukin-33, interleukin-17A, and activated CD1c+ dendritic cells, suggesting these factors drive disease pathogenesis through IL-33-induced DC maturation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

BACKGROUND: Endometriosis (EMS) is a chronic inflammatory disorder involving ectopic endometrial tissue growth. This study investigated IL-33, CD1c+ dendritic cells (DCs) and their co-stimulatory molecules (CD40, CD80, CD86), and IL-17 A in the peritoneal fluid (PF) of EMS patients, and explored their interrelationships. METHODS AND RESULTS: PF samples were obtained from 42 women with EMS as experimental subjects and 31 women without EMS as controls. Enzyme-linked immunosorbent assay (ELISA) showed that PF IL-33 (P < 0.001) and IL-17 A (P < 0.01) levels were significantly elevated in EMS patients vs. controls. Moreover, IL-33 levels were significantly higher in stages III-IV than I-II (P  0.05). However, the proportions of CD1c+CD40+ (P < 0.001), CD1c+CD80+ (P < 0.05), and CD1c+CD86+ (P < 0.01) DCs were significantly elevated in EMS, with CD1c+CD40 + higher in stages III-IV vs. I-II (P < 0.05). For in vitro experiments, control PF mononuclear cells (PFMCs) were incubated with recombinant IL-33 (100 ng/mL) for 24 h. IL-33 treatment increased IL-17 A production and CD1c+CD40 + and CD1c+CD80 + DC frequences in control PFMCs compared to unstimulated PFMCs (all P < 0.05). CONCLUSION: Elevated IL-33 and IL-17 A levels, along with enhanced CD1c + DC maturation and activation in PF, may contribute to EMS pathogenesis and progression. IL-33 may promote disease development by inducing CD1c + DC maturation/activation, thus increasing IL-17 A production.

My notes (saved in your browser only)

MeSH descriptors

Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1 Antigens, CD1

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (50)

SciLite annotations

organisms 3
noordeloos 2009062 noordeloos 2009062 talaromyces euchlorocarpius

Source provenance

europepmc
last seen: 2026-10-16T06:09:50.462052+00:00
openalex
last seen: 2026-10-16T06:01:16.192504+00:00
pubmed
last seen: 2026-10-16T06:03:04.293121+00:00
scilite
last seen: 2026-08-23T10:03:07.687773+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine